|
Feb 24, 2021
|
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
|
|
|
Feb 19, 2021
|
GBT Announces Participation in Upcoming Investor Conferences
|
|
|
Feb 17, 2021
|
GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
|
|
|
Feb 05, 2021
|
GBT Announces New Employment Inducement Grants
|
|
|
Feb 04, 2021
|
GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
|
|
|
Jan 27, 2021
|
European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
|
|
|
Jan 07, 2021
|
GBT Announces New Employment Inducement Grants
|
|
|
Jan 05, 2021
|
GBT Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
|
|